Pharmalucence issued with FDA warning letter
The US Food and Drug Administration (FDA) has issued a warning letter to Pharmalucence for alleged deviations from current good manufacturing practices (cGMP).
Archives for October 30, 2008
Synexus expands in South Africa
Synexus is to more than double its clinical trial capacity in South Africa, in response to a successful couple of years in the nation.
Jubilant rejigs North American operations
Jubilant Organosys, India's largest custom research and manufacturing services (CRAMS) provider, has reorganised its business in North America in the wake of its recent acquisitions of HollisterStier Laboratories and Draxis Specialty Pharmaceuticals.
SAFC showcases HPAPI handling capabilities
SAFC's Mike Harris sets out the firm's role in the expanding high-potency active pharmaceutical ingredient (HPAPI) industry.
Stable growth in 2009 will reflect new shape of drug market, say IMS
Next year, drug revenues will grow 5 per cent to $820bn according to IMS Health, as the global downturn, patent expiry and flat-lining growth rates in mature markets all make their presence felt.
PPP funds Indian technology park
The Indian state of Orissa and a biotech company have entered into a public-private partnership (PPP) to construct a $20m technology park.
Tough times continue at PharmaNet
Clinical research specialist PharmaNet Development Group reported a decline in both sales and earnings for the third quarter but has kept its guidance for the financial year at the same level, albeit excluding an as-yet unresolved impairment charge.